(Q51806570)

12 April 2018

title

Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis (English)

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

25 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

25 March 2024

author name string

Carl Kjellstrand

2

1 reference

12 April 2018

Terri Freitas

3

1 reference

12 April 2018

Shahrzad Zarghamee

5

1 reference

12 April 2018

George O. Ting

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582046

25 March 2024

Brian J. Carrie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582046

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582046

25 March 2024

publication date

1 November 2003

1 reference

12 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S027263860301059X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

https://api.elsevier.com/content/article/PII:S027263860301059X?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

American Journal of Kidney Diseases

25 March 2024

published in

1 reference

12 April 2018

volume

42

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

1020-1035

1 reference

12 April 2018

Dose of hemodialysis and survival: differences by race and sex.

cites work

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.280.20.1764

Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use?

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/01.ASN.0000043902.30577.C9

The quality of life of patients with end-stage renal disease

1

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Quality of life in end-stage renal disease patients

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Changes in quality of life after renal transplantation.

25 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Differences in quality of life across renal replacement therapies: A meta-analytic comparison

25 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The dose of hemodialysis and patient mortality

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Effect of dialysis dose and membrane flux in maintenance hemodialysis

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Fifteen years of clinical experience with daily haemodialysis

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Dialysis with increased frequency of sessions (Lecce dialysis).

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Clinical and biochemical correlates of starting "daily" hemodialysis

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Nightly Home Hemodialysis: Fifteen Months of Experience in Lynchburg, Virginia

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients

25 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Time Needed to Improve Clinical Parameters By Daily Hemodialysis

25 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The current place of urea kinetic modelling with respect to different dialysis modalities

25 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease

25 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Prescribing hemodialysis: the role of gender

25 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Quantification of dialysis unphysiology

25 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Benefits of more frequent dialysis: lower TAC at the same Kt/V.

25 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Daily hemodialysis efficiency: an analysis of solute kinetics.

25 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Daily Hemodialysis versus Standard Hemodialysis: TAC, TAD, Weekly eKt/V, std(Kt/V), and PCRn

25 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The equivalent renal urea clearance: a new parameter to assess dialysis dose

25 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Importance of treatment time and blood pressure control in achieving long-term survival on dialysis

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?

25 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease

25 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease.

25 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

The rate and control of baseline red cell production in hematologically stable patients with uremia

25 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Anemia of end-stage renal disease (ESRD).

25 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Nightly home hemodialysis: improvement in nutrition and quality of life.

25 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients

25 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Dialysis adequacy and health related quality of life in hemodialysis patients.

25 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Survival of vascular access during daily and three times a week hemodialysis

25 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients

25 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Effect of Hemodialysis on Protein C, Protein S, and Antithrombin III Levels

25 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

6-year experience with the creation and use of internal arteriovenous fistulae in patients treated with repeated hemodialysis

25 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Comorbidity and its change predict survival in incident dialysis patients

25 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial

25 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

25 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients.

25 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.020

25 March 2024

Identifiers

1 reference

12 April 2018

1 reference

12 April 2018